E-DRUG: Pharmaceutical policy and other summer courses in Utrecht, the Netherlands
------------------------------------------------------------------
[For information and course registration go to http://www.utrechtsummerschool.nl/ ]
Dear e-druggers,
This summer, the Division of Pharmacoepidemiology and Clinical Pharmacology at Utrecht University, the Netherlands, offers you three challenging international summer courses. All courses will cover the key issues in each field and focus on the most important research methods used. All course teachers have extensive expertise in their field.
M7 Pharmaceutical Policy Analysis (4-8 July 2011)
Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.
The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.
You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation; access, affordability and reimbursement systems; regulatory issues and challenges; policy and politics; synthesis, case studies & public health
Course director
Prof. Dr. Bert Leufkens, Dr. Richard Laing (World Health Organization) and Dr. Aukje Mantel.
Scholarships
For this course, a few scholarships are available for participants from resource limited settings belonging to the target groups (see below). The scholarship includes a waiver of the course fee, student accommodation as described on the summer school website for the period 1-8 July 2011, and a small daily allowance for food and local travel (fixed amount per day). International travel expenses should be borne by the participant or his/her employer. If you wish to apply for a scholarship, please send your CV + a letter of motivation to Dr. Aukje Mantel (a.k.mantel@uu.nl), before 15 April 2011. Final decisions will be reached by 1 May 2011.
M8 Pharmacoepidemiology & Drug Safety (27 June - 1 July 2011)
With the prospect that innovative drug therapies will be introduced in the coming years, society demands new approaches and concepts for comparative risk/benefit evaluation. Assessment of safety and risk management of different drug therapies is done in the framework of observational epidemiological studies (proof of 'safety', proof of 'effectiveness'). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drugs 'efficacy'.
The course will cover key issues in pharmacoepidemiologic and drug safety research. Special topics include databases and molecular pharmacoepidemiology. Students will learn about the typical problems (e.g. confounding by indication, rare side effects) and approaches to deal with these problems in the practice of pharmacoepidemiology.
You will experience an intensive programme covering the following topics:
Study Design and Methods; Confounding and other biases; Methods in drug safety research; Drug Safety and Risk Management; Overview of Pharmacoepidemiological databases; Molecular Pharmacoepidemiology; Drug utilization research; Synthesis, case studies & public health
Course director
Dr. O.H. Klungel and Dr. T.P. van Staa
Lecturers
Prof. S. Suissa, Prof. H.G.M. Leufkens, Prof. A. de Boer, Prof. A.C.G. Egberts, Dr. O.H. Klungel, Dr. T.P. van Staa, Dr. A.H. Maitland-van der Zee, Dr. F. de Vries.
Scholarships
None available
M14 Pharmacoeconomics (11-15 July 2011)
Today's society is confronted with ever increasing health care costs. One of the factors is the cost of drug innovations. Diseases waiting for therapeutic solutions are complicated and multifactorial in nature. As a result, drug innovation has become even more complex leading to high tech and therefore high cost solutions. The question arises, what is the added value of such high cost innovations and how can it be determined when both benefit and harm are considered. Health economics, and more specific pharmacoeconomics, aims to provide a neutral scientific approach to this challenge.
This course aims to provide a broad perspective of the field, including a variety of subjects from views of the different stakeholders to more in depth methodological approaches, illustrated with examples and exercises.
You will experience an intensive programme covering the following topics:
Pharmacoeconomic techniques; Study designs and methods; Critical appraisal of pharmacoeconomic studies; The (im)possibilities of the use of HTA and pharmacoeconomics in regulatory decisions; The economics of personalized medicine; Pharmacoeconomics of orphan drugs
Course director
Dr. A.H. Maitland-van der Zee and Dr. A. Hovels
Lecturers
Prof. J. Raaijmakers, Dr. O.H Klungel, Dr. A.H. Maitland-van der Zee and Dr. A. Hovels, and others
Scholarships
None available
General information for all courses
Target groups
Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge public health/medicine who have an interest in the policy aspects of pharmaceuticals, pharmacoepidemiology and/or pharmacoeconomics.
Fee and combinations
EUR 900,- per course (including course materials + lunches + course dinner, excluding housing). Combination fee for two courses is EUR 1400,- (excluding housing), combination fee for all three courses combined is EUR 1800,- (excluding housing). Student accommodation is available for EUR 200,- per week.
Deadline for application
31 May 2011, see www.utrechtsummerschool.nl <http://www.utrechtsummerschool.nl/> (information summer school and course registration)
Aukje Mantel-Teeuwisse, PhD
Managing director WHO Collaborating Centre for Pharmacoepidemiology & Pharmaceutical Policy Analysis
<http://www.pharmaceuticalpolicy.nl/>
Utrecht Institute for Pharmaceutical Sciences | Division Pharmacoepidemiology & Clinical Pharmacology | PO Box 80 082 | 3508 TB Utrecht | The Netherlands | Tel: +31 6 22736017 or +31 30 253 7324 (secretariate)
WE HAVE MOVED TO A NEW BUILDING:
David de Wied building | Universiteitsweg 99 | 3584 CG Utrecht | the Netherlands
Please note that our postal address will remain the same
"Mantel-Teeuwisse, A.K. (Aukje)" <A.K.Mantel@uu.nl>